CUAMC
BBOT

China Universal Asset Management Company’s BridgeBio Oncology BBOT Stock Holding History

China Universal Asset Management Company’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,000
Closed -$57.9K – 537
2025
Q3 		$57.9K Buy
+5,000
New +$52.1K ﹤0.01% 421

Other funds holding BBOT

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

China Universal Asset Management Company's BBOT Position: Q4 2025 in Review

China Universal Asset Management Company sold out of BridgeBio Oncology (BBOT) in Q4 2025, closing a stake of 5,000 shares — an estimated $57.9K sold.

China Universal Asset Management Company first reported a position in BBOT in Q3 2025 and held it in 1 quarter. The position peaked at $57.9K in Q3 2025. 53 funds tracked by Wall St. Rank hold BBOT as of Q4 2025.

  • China Universal Asset Management Company reported no remaining BridgeBio Oncology position as of Q4 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 5,000 BridgeBio Oncology shares in Q4 2025, an estimated $57.9K.
  • China Universal Asset Management Company first reported a position in BridgeBio Oncology in Q3 2025 and held it in 1 quarter.
  • China Universal Asset Management Company's BridgeBio Oncology position peaked at $57.9K in Q3 2025.
  • 53 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q4 2025.

Based on China Universal Asset Management Company's 13F filing for Q4 2025, filed 29 Jan 2026.